Loading...

Endomines

HLSE:ENDOM
Snowflake Description

High growth potential and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ENDOM
HLSE
SEK215M
Market Cap
  1. Home
  2. FI
  3. Materials
Company description

Endomines AB (publ) engages in exploring, developing, and mining gold concentrates in Finland, and the United States. The last earnings update was 70 days ago. More info.


Add to Portfolio Compare Print
  • Endomines has significant price volatility in the past 3 months.
ENDOM Share Price and Events
7 Day Returns
-1.7%
HLSE:ENDOM
-1.7%
Europe Metals and Mining
0.8%
FI Market
1 Year Returns
-19.8%
HLSE:ENDOM
-4.2%
Europe Metals and Mining
3%
FI Market
ENDOM Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Endomines (ENDOM) -1.7% -5.3% -18.2% -19.8% -75% -97.6%
Europe Metals and Mining -1.7% 4.5% 12.4% -4.2% 56.9% 17.6%
FI Market 0.8% 2.4% 4.5% 3% 27.3% 37.6%
1 Year Return vs Industry and Market
  • ENDOM underperformed the Metals and Mining industry which returned -4.2% over the past year.
  • ENDOM underperformed the Market in Finland which returned 3% over the past year.
Price Volatility
ENDOM
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Endomines undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Endomines to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Endomines.

HLSE:ENDOM Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 2 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 10.5%
Perpetual Growth Rate 10-Year FI Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for HLSE:ENDOM
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year FI Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 6%
Metals and Mining Unlevered Beta Simply Wall St/ S&P Global 1.13
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.132 (1 + (1- 22%) (98.97%))
1.674
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.67
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.54% + (1.674 * 5.96%)
10.52%

Discounted Cash Flow Calculation for HLSE:ENDOM using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Endomines is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

HLSE:ENDOM DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (SEK, Millions) Source Present Value
Discounted (@ 10.52%)
2019 -90.00 Analyst x1 -81.44
2020 -153.00 Analyst x1 -125.27
2021 -15.00 Analyst x1 -11.11
2022 151.00 Analyst x1 101.22
2023 210.00 Analyst x1 127.38
2024 258.42 Est @ 23.06% 141.83
2025 300.55 Est @ 16.3% 149.26
2026 335.34 Est @ 11.57% 150.68
2027 363.05 Est @ 8.26% 147.61
2028 384.64 Est @ 5.95% 141.51
Present value of next 10 years cash flows SEK741.67
HLSE:ENDOM DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= SEK384.64 × (1 + 0.54%) ÷ (10.52% – 0.54%)
SEK3,876.29
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= SEK3,876.29 ÷ (1 + 10.52%)10
SEK1,426.10
HLSE:ENDOM Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= SEK741.67 + SEK1,426.10
SEK2,167.77
Equity Value per Share
(SEK)
= Total value / Shares Outstanding
= SEK2,167.77 / 35.41
SEK61.22
HLSE:ENDOM Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in HLSE:ENDOM represents 0.09441x of OM:ENDO
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.09441x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (SEK) x Listing Adjustment Factor
= SEK 61.22 x 0.09441
€5.78
Value per share (EUR) From above. €5.78
Current discount Discount to share price of €0.57
= -1 x (€0.57 - €5.78) / €5.78
90.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Endomines is available for.
Intrinsic value
>50%
Share price is €0.57 vs Future cash flow value of €5.78
Current Discount Checks
For Endomines to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Endomines's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Endomines's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Endomines's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Endomines's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
HLSE:ENDOM PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in SEK SEK-1.10
OM:ENDO Share Price ** OM (2019-04-25) in SEK SEK6.08
Europe Metals and Mining Industry PE Ratio Median Figure of 106 Publicly-Listed Metals and Mining Companies 9.63x
Finland Market PE Ratio Median Figure of 108 Publicly-Listed Companies 19.89x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Endomines.

HLSE:ENDOM PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OM:ENDO Share Price ÷ EPS (both in SEK)

= 6.08 ÷ -1.10

-5.55x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Endomines is loss making, we can't compare its value to the Europe Metals and Mining industry average.
  • Endomines is loss making, we can't compare the value of its earnings to the Finland market.
Price based on expected Growth
Does Endomines's expected growth come at a high price?
Raw Data
HLSE:ENDOM PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -5.55x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
42.2%per year
Europe Metals and Mining Industry PEG Ratio Median Figure of 62 Publicly-Listed Metals and Mining Companies 0.69x
Finland Market PEG Ratio Median Figure of 91 Publicly-Listed Companies 1.66x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Endomines, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Endomines's assets?
Raw Data
HLSE:ENDOM PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in SEK SEK7.16
OM:ENDO Share Price * OM (2019-04-25) in SEK SEK6.08
Europe Metals and Mining Industry PB Ratio Median Figure of 214 Publicly-Listed Metals and Mining Companies 0.94x
Finland Market PB Ratio Median Figure of 142 Publicly-Listed Companies 2.01x
HLSE:ENDOM PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OM:ENDO Share Price ÷ Book Value per Share (both in SEK)

= 6.08 ÷ 7.16

0.85x

* Primary Listing of Endomines.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Endomines is good value based on assets compared to the Europe Metals and Mining industry average.
X
Value checks
We assess Endomines's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Metals and Mining industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Metals and Mining industry average (and greater than 0)? (1 check)
  5. Endomines has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Endomines expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
42.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Endomines expected to grow at an attractive rate?
  • Endomines's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • Endomines's earnings growth is expected to exceed the Finland market average.
  • Endomines's revenue growth is expected to exceed the Finland market average.
Annual Growth Rates Comparison
Raw Data
HLSE:ENDOM Future Growth Rates Data Sources
Data Point Source Value (per year)
HLSE:ENDOM Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 42.2%
HLSE:ENDOM Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 37.3%
Europe Metals and Mining Industry Earnings Growth Rate Market Cap Weighted Average 1.7%
Europe Metals and Mining Industry Revenue Growth Rate Market Cap Weighted Average 0.9%
Finland Market Earnings Growth Rate Market Cap Weighted Average 15.4%
Finland Market Revenue Growth Rate Market Cap Weighted Average 1.6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
HLSE:ENDOM Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in SEK Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
HLSE:ENDOM Future Estimates Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 637 1
2022-12-31 332 -13 2
2021-12-31 207 98 5 2
2020-12-31 72 4 -30 2
2019-12-31 70 -11 -43 2
HLSE:ENDOM Past Financials Data
Date (Data in SEK Millions) Revenue Cash Flow Net Income *
2018-12-31 105 -8 -37
2018-09-30 126 -8 -58
2018-06-30 128 -10 -51
2018-03-31 120 -9 -55
2017-12-31 121 1 -69
2017-09-30 129 -7 -115
2017-06-30 128 -4 -119
2017-03-31 115 -7 -122
2016-12-31 102 -14 -125
2016-09-30 93 -47 -126
2016-06-30 96 -70 -132
2016-03-31 98 -78 -147

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Endomines's earnings are expected to grow significantly at over 20% yearly.
  • Endomines's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
HLSE:ENDOM Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from Endomines Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

HLSE:ENDOM Future Estimates Data
Date (Data in SEK Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31
2022-12-31 -0.28 -0.28 -0.28 1.00
2021-12-31 0.11 0.62 -0.41 2.00
2020-12-31 -0.62 -0.52 -0.72 2.00
2019-12-31 -1.03 -1.02 -1.03 2.00
HLSE:ENDOM Past Financials Data
Date (Data in SEK Millions) EPS *
2018-12-31 -1.10
2018-09-30 -2.09
2018-06-30 -2.33
2018-03-31 -3.83
2017-12-31 -6.60
2017-09-30 -10.95
2017-06-30 -11.32
2017-03-31 -10.47
2016-12-31 -12.49
2016-09-30 -14.06
2016-06-30 -16.72
2016-03-31 -21.38

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Endomines is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Endomines's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Endomines has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Endomines performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Endomines's growth in the last year to its industry (Metals and Mining).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Endomines does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Endomines's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Endomines's 1-year growth to the Europe Metals and Mining industry average as it is not currently profitable.
Earnings and Revenue History
Endomines's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Endomines Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

HLSE:ENDOM Past Revenue, Cash Flow and Net Income Data
Date (Data in SEK Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 105.32 -37.38 28.66
2018-09-30 126.08 -58.41 30.73
2018-06-30 127.51 -50.72 31.00
2018-03-31 120.00 -55.20 31.39
2017-12-31 121.40 -69.25 31.13
2017-09-30 128.63 -114.80 30.04
2017-06-30 128.35 -118.72 29.94
2017-03-31 114.51 -122.40 29.73
2016-12-31 102.08 -125.02 28.48
2016-09-30 92.80 -126.09 30.30
2016-06-30 95.86 -132.48 34.42
2016-03-31 98.12 -147.20 37.35
2015-12-31 113.49 -164.96 42.42
2015-09-30 127.32 -91.11 44.33
2015-06-30 144.74 -77.94 42.54
2015-03-31 167.73 -50.41 41.46
2014-12-31 173.65 -35.21 42.19
2014-09-30 172.98 -65.00 43.77
2014-06-30 179.21 -68.49 47.17
2014-03-31 161.51 -75.44 51.29
2013-12-31 164.05 -63.32 52.77
2013-09-30 197.05 13.20 54.25
2013-06-30 185.00 12.28 52.25
2013-03-31 240.77 23.66 50.88
2012-12-31 235.09 18.90 48.03
2012-09-30 196.32 -33.93 44.85
2012-06-30 203.80 -5.83 43.73

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Endomines has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Endomines has efficiently used its assets last year compared to the Europe Metals and Mining industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Endomines improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Endomines's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Metals and Mining industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Endomines has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Endomines's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Endomines's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Endomines's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Endomines's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Endomines's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Endomines Company Filings, last reported 3 months ago.

HLSE:ENDOM Past Debt and Equity Data
Date (Data in SEK Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 251.69 213.06 18.93
2018-09-30 265.55 210.60 62.43
2018-06-30 285.52 207.70 90.05
2018-03-31 271.68 205.08 103.60
2017-12-31 45.38 83.56 15.81
2017-09-30 84.06 82.11 13.82
2017-06-30 92.90 83.34 12.39
2017-03-31 102.21 82.71 17.86
2016-12-31 114.54 83.56 29.44
2016-09-30 200.41 84.96 46.38
2016-06-30 210.01 84.01 53.30
2016-03-31 221.42 83.30 70.19
2015-12-31 168.60 83.44 19.99
2015-09-30 251.63 60.90 34.38
2015-06-30 257.89 60.79 67.43
2015-03-31 276.02 62.49 93.06
2014-12-31 317.80 65.50 114.16
2014-09-30 236.13 64.71 34.62
2014-06-30 237.25 65.34 32.63
2014-03-31 236.73 64.79 32.96
2013-12-31 267.93 67.20 45.87
2013-09-30 275.91 71.29 83.07
2013-06-30 303.83 78.72 100.22
2013-03-31 191.94 76.05 85.53
2012-12-31 135.70 80.16 69.16
2012-09-30 53.09 72.61 72.69
2012-06-30 91.05 76.34 29.79
  • Endomines's level of debt (84.6%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (25.1% vs 84.6% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Endomines has less than a year of cash runway based on current free cash flow.
  • Endomines has less than a year of cash runway if free cash flow continues to reduce at historical rates of -15.9% each year.
X
Financial health checks
We assess Endomines's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Endomines has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Endomines's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Endomines dividends. Estimated to be 1.37% next year.
If you bought €2,000 of Endomines shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Endomines's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Endomines's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
HLSE:ENDOM Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
Europe Metals and Mining Industry Average Dividend Yield Market Cap Weighted Average of 65 Stocks 5.8%
Finland Market Average Dividend Yield Market Cap Weighted Average of 101 Stocks 4.2%
Finland Minimum Threshold Dividend Yield 10th Percentile 1.4%
Finland Bottom 25% Dividend Yield 25th Percentile 2.2%
Finland Top 25% Dividend Yield 75th Percentile 4.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

HLSE:ENDOM Future Dividends Estimate Data
Date (Data in SEK) Dividend per Share (annual) Avg. No. Analysts
2023-12-31
2022-12-31
2021-12-31 0.25 1.00
2020-12-31 0.00 1.00
2019-12-31 0.00 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Endomines has not reported any payouts.
  • Unable to verify if Endomines's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Endomines's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Endomines has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Endomines's dividends in 3 years as they are not expected to pay a notable one for Finland.
X
Income/ dividend checks
We assess Endomines's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.4%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Endomines afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Endomines has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Endomines's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Saila Miettinen-Lähde
AGE 56
TENURE AS CEO 1.9 years
CEO Bio

Mrs. Saila Miettinen-Lähde, M.Sc.(Eng.), has been the Chief Executive Officer at Endomines AB (publ) since May 1, 2017. Mrs. Miettinen-Lähde served as the Chief Financial Officer of F-Secure Oyj since February 23, 2015 until February 16, 2017 and its Member of the Leadership Team since 2015. Mrs. Miettinen-Lähde served as the Chief Financial Officer of Talvivaara Mining Company PLC from 2005 to 2015 and also served as its since Deputy Chief Executive Officer since April 1, 2012 until February 1, 2015. She covered Talvivaara's financial management, investor relations, treasury, risk management and communications. Her other previous employers include SIDOS Partners Ltd (2004), Orion Pharma (2000), Finnish National Fund for Research and Development (from 1998 to 1999) and various positions at Leiras Oy. She was a founding partner of SIDOS Partners Ltd from January 2004 to December 2004. From January 2000 to October 2000, She served as Vice President of Business Development at Orion Pharma. She served as a Director of Outokumpu Oyj from March 26, 2015 to June 9, 2017. She served as a Non-Executive Director at Rautaruukki Corporation since March 14, 2012. She served as a Director at D. Carnegie AB from 2000 to 2003. She served as Executive Director of Talvivaara Mining Company PLC from 2007 to April 2012. From 1998 to 1999, Mrs. Miettinen-Lähde served as a Director of the Finnish National Fund for Research and Development and she held various positions at Leiras Oy from 1993 to 1998. She served as Non-Executive Director at Biohit Oyj since April 13, 2011. She holds a Master of Science degree in engineering from the Tampere University of Technology.

CEO Compensation
  • Insufficient data for Saila to compare compensation growth.
  • Insufficient data for Saila to establish whether their remuneration is reasonable compared to companies of similar size in Finland.
Management Team Tenure

Average tenure and age of the Endomines management team in years:

1.3
Average Tenure
47
Average Age
  • The average tenure for the Endomines management team is less than 2 years, this suggests a new team.
Management Team

Saila Miettinen-Lähde

TITLE
Chief Executive Officer
AGE
56
TENURE
1.9 yrs

Marcus Ahlström

TITLE
Chief Financial Officer
AGE
36
TENURE
1.3 yrs

Esa Sandberg

TITLE
Chief Geologist

Seppo Tuovinen

TITLE
President of Endomines Idaho
AGE
47
TENURE
0.7 yrs
Board of Directors Tenure

Average tenure and age of the Endomines board of directors in years:

2
Average Tenure
67
Average Age
  • The average tenure for the Endomines board of directors is less than 3 years, this suggests a new board.
Board of Directors

Ingmar Haga

TITLE
Chairman of the Board
AGE
67
TENURE
1 yrs

Rauno Pitkänen

TITLE
Director
COMPENSATION
SEK225K
AGE
68
TENURE
9.3 yrs

Michael Mattsson

TITLE
Director
AGE
45
TENURE
2 yrs

Staffan Simberg

TITLE
Director
COMPENSATION
SEK350K
AGE
69
TENURE
8 yrs

Thomas Karl Hoyer

TITLE
Director
AGE
44
TENURE
1 yrs
Who owns this company?
Recent Insider Trading
  • Endomines insiders have only sold shares in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
24. Mar 19 Sell Michael Mattsson Individual 22. Mar 19 22. Mar 19 -6,000 €0.62 €-3,718
X
Management checks
We assess Endomines's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Endomines has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Endomines AB (publ) engages in exploring, developing, and mining gold concentrates in Finland, and the United States. The company owns 6 mining concessions covering 418.4 hectares; 64 claims with 5073.4 hectares; and 17 exploration permits consisting of 3995.1 hectares located in the Karelian Gold Line. It also operates Koivu, Kaire, Perä, Riutta, and Lyly ilmenite deposits located in Kälviä area in Western Finland. In addition, the company operates Rescue, Kimberly, Buffalo Gulch, and Deadwood projects located in Idaho. Endomines AB (publ) is based in Stockholm, Sweden.

Details
Name: Endomines AB (publ)
ENDOM
Exchange: HLSE
Founded:
SEK20,278,453
35,407,488
Website: http://www.endomines.com
Address: Endomines AB (publ)
Birger Jarlsgatan 41 A 3 tr,
Stockholm,
Stockholm County, 111 45,
Sweden
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OM ENDO Common Shares OMX Nordic Exchange Stockholm SE SEK 19. Jun 2007
LSE 0RFY Common Shares London Stock Exchange GB SEK 19. Jun 2007
HLSE ENDOM Common Shares OMX Nordic Exchange Helsinki FI EUR 19. Jun 2007
Number of employees
Current staff
Staff numbers
24
Endomines employees.
Industry
Gold
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/25 22:06
End of day share price update: 2019/04/25 00:00
Last estimates confirmation: 2019/02/15
Last earnings filing: 2019/02/14
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.